A new Joint Position Statement highlighting fracture-related risk factors in patients treated by aromatase-inhibitors and outlining key management strategies to help prevent bone loss and related fractures.
The Statement is authored by experts from the International Osteoporosis Foundation (IOF), Cancer and Bone Society (CABS), European Calcified Tissue Society (ECTS), International Expert Group for AIBL (IEG), European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Menopause Society (IMS), and the International Society for Geriatric Oncology (SIOG).
The Joint AIBL position paper is published in the Journal of Bone of Oncology and abstract available at https://www.ncbi.nlm.nih.gov/pubmed/28413771